New gene therapy proves effective in treating severe heart failure

Researchers have developed a new gene therapy that is safe and effective in reversing advanced heart failure. SERCA2a is a gene therapy designed to stimulate production of an enzyme that enables the failing heart to pump more effectively. In a Phase II study, SERCA2a injection through a routine minimally invasive cardiac catheterization was safe and showed clinical benefit in treating this patient population and decreasing the severity of heart failure.

Read the whole article on Science Daily

More from Science Daily